Pages that link to "Q36320257"
Jump to navigation
Jump to search
The following pages link to Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes. (Q36320257):
Displaying 50 items.
- Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspective (Q27009221) (← links)
- Gender differences in murine pulmonary responses elicited by cellulose nanocrystals (Q28396338) (← links)
- Virtual Experiments Enable Exploring and Challenging Explanatory Mechanisms of Immune-Mediated P450 Down-Regulation (Q28552467) (← links)
- Assessment of Disease-Related Therapeutic Protein Drug-Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative Colitis (Q28597396) (← links)
- Hepatic gene expression profiling reveals protective responses in Atlantic salmon vaccinated against furunculosis (Q33514116) (← links)
- Emergency open cholecystectomy is associated with markedly lower incidence of postoperative nausea and vomiting (PONV) than elective open cholecystectomy: a retrospective cohort study (Q33530925) (← links)
- The transcriptional regulation of the human CYP2C genes (Q33597311) (← links)
- Disease-Drug Interaction of Sarilumab and Simvastatin in Patients with Rheumatoid Arthritis (Q33658743) (← links)
- Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications (Q33714587) (← links)
- The correlation between the expression of genes involved in drug metabolism and the blood level of tacrolimus in liver transplant receipts (Q33793971) (← links)
- DEC1 binding to the proximal promoter of CYP3A4 ascribes to the downregulation of CYP3A4 expression by IL-6 in primary human hepatocytes (Q33869682) (← links)
- Pharmacokinetics of mycophenolic acid in patients with lupus nephritis (Q33984216) (← links)
- Pregnane X receptor is required for interleukin-6-mediated down-regulation of cytochrome P450 3A4 in human hepatocytes (Q34101899) (← links)
- A clinical therapeutic protein drug-drug interaction study: coadministration of denosumab and midazolam in postmenopausal women with osteoporosis (Q34286862) (← links)
- Inflammation is associated with voriconazole trough concentrations. (Q34597394) (← links)
- Transcriptional Regulation of the Human P450 Oxidoreductase Gene: Hormonal Regulation and Influence of Promoter Polymorphisms (Q34856488) (← links)
- Relationship between differential hepatic microRNA expression and decreased hepatic cytochrome P450 3A activity in cirrhosis (Q34994708) (← links)
- Selective role for tumor necrosis factor-α, but not interleukin-1 or Kupffer cells, in down-regulation of CYP3A11 and CYP3A25 in livers of mice infected with a noninvasive intestinal pathogen (Q35072031) (← links)
- Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics (Q35114057) (← links)
- Modulation of hepatic cytochrome P450s by Citrobacter rodentium infection in interleukin-6- and interferon-{gamma}-null mice (Q35454343) (← links)
- Immunological response as a source to variability in drug metabolism and transport (Q35749503) (← links)
- The role of the immune system in nevirapine-induced subclinical liver injury of a rat model (Q36200176) (← links)
- Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patients (Q36243677) (← links)
- Molecular mechanisms of genetic variation and transcriptional regulation of CYP2C19. (Q36307008) (← links)
- Maternal obesity alters feto-placental cytochrome P4501A1 activity (Q36417384) (← links)
- Monocyte-induced recovery of inflammation-associated hepatocellular dysfunction in a biochip-based human liver model (Q36605868) (← links)
- Pharmacokinetic and pharmacodynamic properties of canakinumab, a human anti-interleukin-1β monoclonal antibody (Q36644667) (← links)
- Profiling of hepatic clearance pathways of Pittsburgh compound B and human liver cytochrome p450 phenotyping (Q36690141) (← links)
- CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype (Q36944006) (← links)
- Effects of commonly used excipients on the expression of CYP3A4 in colon and liver cells (Q37031501) (← links)
- Regulation of hepatic cytochrome P450 expression in mice with intestinal or systemic infections of citrobacter rodentium (Q37075256) (← links)
- Inflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosing (Q37076331) (← links)
- Dual mechanisms of CYP3A protein regulation by proinflammatory cytokine stimulation in primary hepatocyte cultures. (Q37188039) (← links)
- The effect of ZnO nanoparticles on liver function in rats (Q37234673) (← links)
- Hepatic cytochrome P450s, phase II enzymes and nuclear receptors are downregulated in a Th2 environment during Schistosoma mansoni infection. (Q37422679) (← links)
- Long-term virus-induced alterations of CYP3A-mediated drug metabolism: a look at the virology, immunology and molecular biology of a multi-faceted problem (Q37592262) (← links)
- Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines (Q37604385) (← links)
- Selective effects of a therapeutic protein targeting tumor necrosis factor-alpha on cytochrome P450 regulation during infectious colitis: Implications for disease-dependent drug-drug interactions (Q37679511) (← links)
- 4β-Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of bDMARDs and Correlation With Inflammatory State (Q37700667) (← links)
- CYP-mediated therapeutic protein-drug interactions: clinical findings, proposed mechanisms and regulatory implications (Q37729127) (← links)
- Mechanisms of Monoclonal Antibody–Drug Interactions (Q37799374) (← links)
- The effect of inflammation on drug metabolism: a focus on pediatrics (Q37849895) (← links)
- Interleukin-6 and cytochrome-P450, reason for concern? (Q37997359) (← links)
- Cytokines as molecular targets for aryl hydrocarbon receptor ligands: implications for toxicity and xenobiotic detoxification (Q38066512) (← links)
- Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies (Q38072598) (← links)
- Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids. (Q38138158) (← links)
- Cancer, inflammation, and therapy: effects on cytochrome p450-mediated drug metabolism and implications for novel immunotherapeutic agents. (Q38225574) (← links)
- Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014. (Q38284468) (← links)
- Vaccine-Drug Interactions: Cytokines, Cytochromes, and Molecular Mechanisms. (Q38560295) (← links)
- Indirect regulation of CYP2C19 gene expression via DNA methylation. (Q38608601) (← links)